Article Details
Retrieved on: 2022-12-29 08:37:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Japan has approved AstraZeneca's Calquence (acalabrutinib), for the treatment of adult patients with treatment-naïve Chronic Lymphocytic Leukaemia ...
Article found on: www.expresspharma.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here